DoW Breast Cancer, Breakthrough Award Levels 1 and 2
Open
Defense Health Agency Contracting Activity - DHACA is offering grants to any type of organization. It expects to make about 6 awards worth $10.6 million in total. Applications close on November 18, 2026.
From the official notice on Grants.gov, last changed September 3, 2026. Checked October 31, 2026.
- Award ceilingnot stated
- Award floornot stated
- Expected awards6
- Total funding$10.6 million
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | September 3, 2026 |
|---|---|
| Deadline | November 18, 2026 |
| Archived by Grants.gov | December 18, 2026 |
Add the deadline to your calendar
Who can apply
This opportunity is open to any type of organization.
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Applications must address the challenge in a way that can lead to a breakthrough and have major impact. The FY26 Breakthrough Award mechanism contains four different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level specifies a distinct research scope. This program announcement discusses the Breakthrough Award Levels 1 and 2. Distinctive Features: * This funding mechanism allows for applications submitted under Funding Level 1 or Funding Level 2. Funding Level 2 also includes a Population Science Studies option. With compelling justification, population science studies may request higher levels of funding and an additional year in the period of performance. * This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal.
How to apply
- Read the full notice and attachments on Grants.gov. The notice is the official source for deadlines and requirements.
- Make sure your organization has an active SAM.gov registration and Unique Entity ID; registration can take several weeks.
- Register on Grants.gov and submit through Workspace before the deadline and time given in the notice. Our application guide walks through each step.
Questions go to Danielle Reckley, Grantor, help@eBRAP.org, 301-619-1139.
Questions people ask
Who can apply for DoW Breast Cancer, Breakthrough Award Levels 1 and 2?
Defense Health Agency Contracting Activity - DHACA accepts applications from any type of organization.
What is the deadline for DoW Breast Cancer, Breakthrough Award Levels 1 and 2?
Closes November 18, 2026 (18 days left). Confirm the date and time in the official notice on Grants.gov.
How much funding is available?
About $10.6 million in total across about 6 awards.
Similar open grants
- RESTORE Act Centers of Excellence Research Grants Program
- Topology
- Geometric Analysis
- Space Technology Research Institutes
- SBE Postdoctoral Research Fellowships (SPRF)
- NSF Small Business Innovation Research / Small Business Technology Transfer Phase I, Phase II, Fast-Track Programs: A Pilot Emphasis on Scientific Instrumentation